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The antibiotic trimethoprim (TMP), a micropollutant found at mg/L levels in raw wastewater, was
investigated with regard to its (bio)transformation during biological wastewater treatment. A pilot-scale,
nitrifying/denitrifying Sequencing Batch Reactor (SBR) fed with municipal wastewater was monitored for
TMP removal during a 16-month monitoring study. Laboratory-scaled bioreactors spiked with TMP were
applied to identify the transformation products (TPs). In total, six TPs could be identiﬁed from TMP.
However, the TP formation was inﬂuenced by the spike concentration. At an initial concentration of
500 mg/L TMP, only two TPs were found, whereas at 5 mg/L a completely different transformation pathway
led to four further TPs. At low concentrations, TMP was demethylated forming 4-desmethyl-TMP, which
was then quickly hydroxylated, oxidized and cleaved forming 2,4-diaminopyrimidine-5-carboxylic acid
(DAPC) via two intermediate TPs. DAPC was detected in the SBR efﬂuent in a 3-d composite sample with
61 ng/L, which accounts for 52% of the attenuated TMP. The primary degradation at low spiking levels
was best modelled by a pseudo-ﬁrst order kinetic. Considering the SBR, the model predicted a TMP
removal of 88e94% for the reactor, consistent with a monitoring campaign exhibiting an average removal
of >83%. Both the TP formation proﬁles and kinetic modelling indicated that only the results from the
bioreactor tests at low spike concentrations were representative of the transformation in the SBR.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The consumption of pharmaceuticals has become a common
and important part of modern healthcare. However, these anthro-
pogenic compounds are a potential hazard to the aquatic envi-
ronment (Luo et al., 2014). Predominantly, these compounds are
released into the local sewer system either by excretion via urine/
faeces or via direct disposal in the toilet. Most wastewater treat-
ment plants (WWTPs) are primarily designed to remove nutrients
and easily degradable carbon compounds. It has been shown that
they have limited capacities to remove pharmaceuticals (Joss et al.,
2006), making them major sources of these micropollutants in
rivers and streams (Metcalfe et al., 2010; Sengupta et al., 2014).
Certain pharmaceuticals, such as antibiotics, are of particular
concern since emission may foster the development of resistant
pathogens discharged into the aquatic environment (Marti et al.,Ltd. This is an open access article u2014). To mitigate the release of micropollutants, an upgrade of
conventional wastewater treatment is currently discussed in many
countries, including Germany (Hillenbrand et al., 2015). In
Switzerland, 2014 saw a revision of the water protection law, which
includes the upgrading of a number of Swiss WWTPs speciﬁcally
for the elimination of micropollutants (Eggen et al., 2014). In
Switzerland, the upgrading approaches are usually based on
advanced treatment such as activated carbon ﬁlters and ozonation,
but there is interest in improving and understanding biological
processes, which are already established.
In the current study the antibiotic trimethoprim (TMP) was
investigated in detail with regard to its removal via biological
wastewater treatment. TMP is an antibiotic usually administered in
combination with sulfamethoxazole. These two antibiotics target
two parts of the bacterial tetrahydrofolic acid synthesis pathway,
which is an important cofactor, e.g. for DNA synthesis (Brogden
et al., 1982). TMP has been detected in WWTP inﬂuents at con-
centrations ranging from 0.14 to 1.3 mg/L and in efﬂuents from 0.02
to 1.3 mg/L (Le-Minh et al., 2010). In rivers, concentrations of up tonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and up to 0.04 mg/L in Japan (Murata et al., 2011). Reports about the
removal of trimethoprim in WWTPs are rather contradictory. In
several studies it has been found that TMP is quite resistant to
biological wastewater treatment (G€obel et al., 2005; Lindberg et al.,
2006), while other studies reported a partial removal of TMP
ranging from 40 to 50% (Batt et al., 2006; Radjenovic et al., 2009) or
even an almost complete removal (Kovalova et al., 2012). However,
the reasons for these different results are currently not known.
Previous reports about the transformation of TMP also exhibit
signiﬁcant differences. In total, ﬁve transformation products (TPs)
of TMP have been identiﬁed, resulting from hydroxylation reactions
and ring opening, but the TPs were not consistent between the
different studies (Brenner et al., 2011; Eichhorn et al., 2005; Yi et al.,
2012). These TPs have been identiﬁed in efﬂuent from an anaerobic
reactor treating hospital wastewater, in reactors fed with synthetic
wastewater or in lab-scale batch reactors, but have still not been
found in municipal WWTPs. Elucidation of TPs is a key aspect of
understanding the possible removal mechanisms of micro-
pollutants and to assess whether toxic or refractory products
remain after transformation. The current interest in the removal of
micropollutants by biological treatment and the growing concern
of antibiotic resistant pathogens support the further assessment of
the relevance of the reported TPs and the associated transformation
pathways of the antibiotic TMP during biological municipal
wastewater treatment.
TMP can be transformed in biological wastewater treatment
systems. Where removal is observed it is often attributed to
removal under aerobic (nitrifying) conditions (Eichhorn et al.,
2005; Yi et al., 2012; Batt et al., 2006). However, it is yet un-
known if the variability of the TMP removal depends on differences
in the investigated treatment processes (G€obel et al., 2007) or if
there is temporal variability at ﬁxed treatment conditions over long
time scales. Since TMP inhibits the DNA synthesis of certain bac-
teria, it cannot be ruled out that elevated TMP concentrations often
used in lab-scale studies alters the transformation reactions as well
as the transformation kinetics. Thus, a deeper look at the aerobic
transformation reactions and kinetics at different TMP concentra-
tions is warranted.
Therefore, the objectives of this study were to i) measure the
variability of TMP removal in an activated sludge system treating
municipal wastewater over a 16-month monitoring period; ii)
measure the kinetics of TMP removal in activated sludge in sludge-
seeded laboratory-scale reactors under aerobic conditions spiked at
different TMP concentrations; iii) investigate the transformation
reactions and removal pathway(s) of TMP in these reactors; and iv)
transfer the ﬁndings of the laboratory studies to the activated
sludge system to assess the relevance to native conditions.
2. Methods
2.1. Pilot-scale sequencing batch reactor
A 12-L suspended sludge Sequencing Batch Reactor (SBR) sit-
uated on the site of a municipal WWTP with 220,000 person
equivalents was used for the study. Incoming municipal waste-
water with average concentrations of 220 mg/L BOD, 70 mg/L Ntot,
and 16 mg/L Ptot was treated mechanically (screening, grit
removal, and sedimentation) at the plant, before being fed to the
pilot reactor. The pilot reactor was operated as a conventional
nitriﬁcation/denitriﬁcation process with ﬁxed operational set-
tings: 10-d Solids Retention Time (SRT), 12-h Hydraulic Retention
Time (HRT), and a batch duration of 3 h (1-h anoxic conditions
followed by 2-h oxic conditions) with a ﬁxed inﬂuent volume. On-
line sensors connected to a programmable logic controller (Wago750e881) and a SCADA system (Citect V7.2, Schneider Electric),
allowed control of dissolved oxygen concentrations during the
oxic phase (1e3 mg/L), and ﬁll levels during all feed and discharge
events (9e12 L) as well as continuous monitoring of temperature
(15e25 C) and pH (7.0e7.5).
Inﬂuent and efﬂuent samples were collected as 3-d composite
samples during a 16-month period. Samples were taken after the
settling phase by an automated sampler with refrigerated storage
containers. After collection, the samples were immediately ﬁltered
(0.45 mm, regenerated cellulose) and stored at 20 C. A stability
test indicated that the compounds of interest were stable during
the 3-day collection period. Further details are given in the
Supplementary data. The samples were monitored for TMP and its
TP concentrations by direct injection, or in some cases via a Solid
Phase Extraction (SPE) enrichment step, as described in section 2.5.
Additional measurements of dissolved organic carbon (DOC) and
inorganic nitrogen species (NO3e-N, NO2e-N, and NH4þ-N) conﬁrmed
a stable removal of DOC averaging 60%, and ammonium removal
averaging 95% during the monitoring period. Detailed parameters
are given in the Supplementary data.
2.2. Chemicals
Trimethoprim (TMP) was purchased from Sigma Aldrich
(Schnelldorf, Germany). Its metabolite 4-desmethyl-TMP the in-
ternal standard trimethoprim-d3 was purchased from Toronto
Research Chemicals (Toronto, Canada). Ethyl 2,4-
diaminopyrimidine-5-carboxylate was purchased from Activate
Scientiﬁc (Prien, Germany). All chemicals used for analysis were of
95% purity.
2.3. Lab-scale bioreactor incubation experiments
To study the fate of trimethoprim in contact with nitrifying
activated sludge, 400 mL bioreactor experiments were set up in
light-protected vessels and inoculated with nitrifying activated
sludge from the SBR. Activated sludge was either diluted 1:1 with
SBR inﬂuent for the low dilution experiments or diluted 20:1 with
SBR efﬂuent for the high dilution experiments. Efﬂuent was chosen
for the 20:1 dilution, since dilutingwith inﬂuent is not practical due
to the large matrix effects of inﬂuent leading to analytical difﬁ-
culties. To test the effect of changing the dilution matrix alone, a
third experiment was conducted with 1:1 sludge dilution with
WWTP efﬂuent. All incubation experiments were conducted with
at least one replicate. Throughout the incubation period, the sludge
was stirred and aerated with a regulated mixture of air and CO2 via
a diffuser. CO2 was added to the gas mixture to compensate for CO2
loss through purging, which would otherwise have led to pH
instability (Wick et al., 2009). The pH was maintained at the same
level as in the pilot-scale SBR (6.5e7.5). TMP was spiked to the
experiments after at least 1 h equilibration time at concentrations
of 5 or 500 mg/L. The lower spike level (5 mg/L) was chosen to ensure
that down to 1% of TP formation from the parent was still within a
detectable range. Control experiments were left unspiked. Further
control experiments without biological activity were run concur-
rently. For these abiotic controls the sludge was ﬁltered (0.2 mm,
polyethersulfone) to remove the microbial biomass. Samples of all
lab-scale experiments were taken at regular intervals, were
immediately ﬁltered (0.45 mm, regenerated cellulose) and were
stored at 4 C prior to analysis via LCetandem MS.
2.4. Kinetic analysis
The degradation kinetics were modelled according to
Schwarzenbach et al. (2005) by either a pseudo-ﬁrst-order rate law
Fig. 1. Concentrations (ng/L) of TMP in 3-day composite samples of inﬂuent and
efﬂuent of a pilot-scale SBR over 16 months of the experiment (7-month start-up
phase and 9-month operational phase).
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d½TMP
dt
¼ kbiol½TMPXss (1)
d½TMP
dt
¼ k0biolXss (2)
where [TMP] is the trimethoprim concentration (mg/L), Xss the
sludge concentration (gSS/L), kbiol is the pseudo-ﬁrst-order rate
constant in L/(gSS$d), and k'biol the zero-order rate constant in mg/
(gSS$d). The uncertainty of kbiol was determined by analysis of 3
replicate batches, or where only 2 replicates were made, by sta-
tistical analysis of the regression.
2.5. Analytical methods
TMP and its TPs other than DAPC were analysed by LCetandem
MS via direct injection using an Agilent HPLC system equippedwith
a ZORBAX Eclipse Plus C18 column (150  2.1 mm, 3.5 mm, Agilent
Technologies) coupled to a Qq-LIT-MS (API 5500 QTRAP, Sciex,
Darmstadt, Germany) with ESI in positive ionization mode. As
mobile phase, water with 0.1% formic acid buffer and methanol
with 0.1% formic acid buffer were used. Quantiﬁcation of TMP was
performed in MRM mode (Multiple Reaction Monitoring) using
trimethoprim-d3 as an internal standard.
High-resolution mass spectra and MSn fragmentation experi-
ments for the identiﬁcation and characterization of TPs were ob-
tained by Orbitrap-MS (LTQ Orbitrap Velos) coupled by ESI to an
Accela HPLC system (both from Thermo Scientiﬁc, Bremen, Ger-
many) running the same chromatographic method as described
above.
Analysis of DAPC in efﬂuent wastewater included a sample
enrichment step using solid phase extraction. Samples were
extracted using ENVI-Carb graphitic carbon cartridges (Sigma
Aldrich) at pH 7. The cartridges were conditioned with 6 mL
methanol and 8 mL of pristine groundwater (pH 7). Wastewater
samples (50 mL, pH 7) were loaded onto the cartridges, which were
then dried under a light nitrogen gas ﬂow and eluted with 10 mL
methanol. The organic phase was evaporated to 0.5 mL at 35 C
under a gentle nitrogen ﬂow. Water (0.3 mL) was added and the
mixture was again evaporated to 0.5 mL. Analysis was carried out
by LCeHRMS on a Q-ToF-MS (5600 TripleTOF, Sciex) coupled by ESI
in positive ionisation mode to an Agilent HPLC system running the
same chromatographic method as described above.
For the quantiﬁcation of DAPC, a direct injection method was
used utilizing LCetandem MS and a standard addition method on
the same Qq-LIT-MS system described. To improve the retention a
different chromatographic method was used. The HPLC was
equipped with a Hypercarb graphitic carbon column
(150  2.1 mm, 3 mm, Thermo Scientiﬁc). The mobile phases for
gradient elution were water and acetonitrile. The water was buff-
ered to pH 10 with 0.1% ammonium formiate, while 0.1% ammonia
was added to acetonitrile.
Detailed instrumental parameters including MRM transitions
used in the above methods are provided in the Supplementary data
section.
3. Results and discussion
3.1. Variability of primary removal over time
The concentrations of TMP were monitored in the pilot-scale
SBR, which was conﬁgured as a nitrifying/denitrifying reactor and
fedwith the primary efﬂuents of amunicipalWWTP as described insection 2.1. Both concentrations in SBR inﬂuent and efﬂuent were
measured in 3-day composite samples. The elevated ﬂuctuations of
the TMP inﬂuent concentration has been observed previously
(Coutu et al., 2013). Variable inﬂuent concentrations of pharma-
ceuticals are a common phenomenon and are linked to temporal/
spatial variability in their use as well as changes inwater ﬂowof the
sewer system (Petrie et al., 2015).
Initially, the removal of TMP was relatively low. During the
initial start-up phase, the average TMP removal was 34% (Fig. 1).
This included a period of heavy rainfall in the catchment area of the
treatment plant, which caused large variations in the measured
TMP removal. These effects can be attributed to dilution of the
wastewater and possible biomass loss in the reactor or varying
dilution of the SBR inﬂuent and efﬂuent samples, which could have
led to the very low removals observed. After the start-up phase the
removal increased and remained relatively constant with an
average of >83% removal during the operational phase. Although
the reactor was able to remove nutrients, nitrogen and other
micropollutants during both periods, the high removal efﬁciency of
TMP was ﬁrst achieved after 7 months of operation.
A TMP removal of >83% is uncharacteristically high for nitrifying
activated sludge reactors with an SRT of 10 d (Batt et al., 2006;
Radjenovic et al., 2009). However, this does not appear to be an
intrinsic process and the removal shows development over time.
Since the removal of TMP is a biological process, as shown in the
next section, this may be attributed to the microbial community in
the reactor which developed in the summer of 2013. Incubation
experiments conducted with the SBR sludge and TMP were there-
fore inoculated with sludge after it had achieved this TMP
degrading ability.3.2. Incubation of trimethoprim in aerobic sludge
The degradation of trimethoprim (TMP) was investigated in lab-
scale bioreactors inoculated with activated sludge from the SBR. To
assess the inﬂuence of the TMP concentration and the effects of the
wastewater matrix on the TMP removal, incubations were per-
formed at different spike levels (5 mg/L and 500 mg/L) and sludge
dilutions (1:1 and 1:20) with inﬂuent wastewater (primary efﬂuent
of the WWTP) or efﬂuent wastewater. To conﬁrm that the removal
in these incubations was associated with the biomass, a control
reactor with sludge ﬁltrate was also established and exhibited no
TMP removal or formation of TPs during 4 days of incubation.
In the ﬁrst set of experiments, the sludge was diluted 1:1 with
inﬂuent wastewater and spiked with TMP at two different
K.S. Jewell et al. / Water Research 88 (2016) 550e557 553concentrations (500 mg/L and 5 mg/L), (Fig. 2a and b). Removal of
TMP was observed in both of these experiments, but proceeded at
different rates (Table 1). The primary degradation at 5 mg/L TMP
(low spike level) was fast, whereas the primary degradation at
500 mg/L TMP (high spike level) was slower.
When the sludge dilution was increased from 1:1 to 1:20 and
the wastewater matrix was changed from inﬂuent to efﬂuent, no
removal of TMP could be observed in the experiment with high
spike level (500 mg/L; Fig. 3a). At the low spike level (5 mg/L, Fig. 3b),
a signiﬁcant dissipation took place. However, this removal was still
slower than in the 1:1 dilution experiment (Fig. 2b).
In the last experiment, 5 mg/L TMP was incubated in sludge
diluted 1:1 with reactor efﬂuent instead of the reactor inﬂuent
(Fig. 3c). The results again show a contrast to the 20:1 dilutionwith
efﬂuent (Fig. 3b), where the removal is much slower (DT50 of 10 d
versus 1 d) (Table 1). The kinetics appears to ﬁt more closely to
Fig. 2b, where inﬂuent dilution was used (also 1:1), albeit with a
longer DT50. Clearly, changing the dilutionmatrix had an impact on
degradation. However, this was not as signiﬁcant as changing the
level of dilution or the spike concentration of TMP.
The data in Figs. 2 and 3 suggest that it would be difﬁcult to ﬁt a
pseudo-ﬁrst-order kinetic model to the degradation shown in Figs.
2a and 3b (high TMP concentration or high sludge dilution). A zero-
order model gives a better ﬁt, shown by the dotted lines. The data
shown in 2b and 3c suggests more typical degradation kinetics that
could ﬁt a pseudo-ﬁrst order rate law. The rate constants for both
kinetic models are given in Table 1. However, further studies at
higher sampling frequency are needed to conﬁrm the kinetic order.
Comparison of pseudo-ﬁrst order rate constants (kbiol), show these
to be highest at low spike concentrations and low dilution. The
zero-order rate constants (k'biol) are based on absolute concentra-
tion changes and are therefore more difﬁcult to compare, but are
also generally higher at low sludge dilution.
For a more accurate determination of the kinetics of TMP
removal, the SBR itself was spiked with 1 mg/L TMP and run in batch
mode (no cycling) for two days. A high sampling frequency (8
samples/d) allowed a clear interpretation of the kinetics showingFig. 2. Time courses of TMP and TPs in lab-scale reactor experiments with activated
sludge diluted with inﬂuent wastewater. TMP (C), TP306 (▫), TP324 (▵), 4-
desmethyl-TMP (-), TP292 (  ), TP290 (:) and DAPC ( ). A: c0 ¼ 500 mg/L; inﬂu-
ent:sludge 1:1 (n ¼ 3), 12-day incubation. The dotted line represents a zero-order
kinetic model. B: c0 ¼ 5 mg/L inﬂuent:sludge 1:1 (n ¼ 2), 4-day incubation.that a pseudo-ﬁrst-order model ﬁts very well (Table 1 and
Supplementary data Fig. S16).
It can be concluded that increasing the TMP to biomass ratio,
either by a higher initial TMP concentration or by a signiﬁcant
sludge dilution, lowers the biological rate constants of TMP. Similar
kinetic effects of higher substrate concentration have also been
observed in degradation studies of ibuprofen (Collado et al., 2012).
More recent studies of TMP degradation have found that rate
constants are not impacted as long as the TMP to COD ratio remains
below 2  103 (Su et al., 2015). This level lies approximately be-
tween the two extreme cases tested in this study (around 1  104
and 2 102). This supports the result that the removal kinetics can
change at higher TMP spike concentration and higher matrix di-
lutions. To further investigate if this is due to changing kinetics of
one primary transformation reaction, as a function of TMP to
biomass ratio, or if multiple transformation reactions are involved,
each with different kinetics, the formation of TPs was elucidated.
3.3. Identiﬁcation of transformation products of TMP removal
The TMP incubation experiments with activated sludge were
analysed by LCeHRMS to identify transformation products (TPs)
and thereby elucidate possible transformation pathways of TMP.
3.3.1. Experiments with high TMP concentration (500 mg/L)
In the experiments with high TMP concentration (Figs. 2a and
3a), in total two TPs were identiﬁed during the incubation period:
TP306 and TP324. Both could be initially characterized by their
chemical formulae and MS2 fragmentation spectra (See
Supplementary data Fig. S2e3). The two TPs matched well with
those reported by Eichhorn et al. (2005) with respect to their exact
masses (i.e. their molecular formulae) and their MS2 fragmentation
spectra. These TPs were present in both high and low sludge-
dilution experiments (Figs. 2a and 3a, respectively), although
TMP dissipation was only observed at low sludge dilution (Fig. 2a).
Quantiﬁcation was impossible since reference standards were not
available. However, by plotting their peak areas as a percentage of
the initial TMP peak area over time, their formation rates were
assessed. In the high dilution experiment, although TP formation
was observed therewas no observable removal of TMP (Fig. 3a). The
low signals of these TPs would suggest they do not represent a
signiﬁcant fraction of TMP removal. TP306 is formed by a hydrox-
ylation, while TP324 is formed by hydroxylations and several
subsequent redox reactions (Scheme 1a).
3.3.2. Experiments with low TMP concentration (5 mg/L)
The TP identiﬁcation in the experiments with 5 mg/L TMP and
with low sludge dilution (1:1) provided a different picture. Sur-
prisingly, four new TPs were found which appeared sequentially as
TMP was degraded. The chemical structures of the TPs were
elucidated by their MS2 fragmentation patterns (see
Supplementary data Fig. S4e7). The time courses of each TP are
shown in Fig. 2b. The ﬁrst three TPs were formed and dissipated in
quick succession, which is typical of intermediates in consecutive
reactions. These also have a low steady-state concentration, which
can be seen from their low peak intensities in comparison to TMP.
The most prominent of these TPs had an m/z-ratio of 277.13, cor-
responding to an exchange of CH3 by a hydrogen atom resulting
from a demethylation of one of the aromatic methoxy moieties
present in TMP. By comparing the retention time and fragmentation
pattern with an analytical standard, the formation of 4-desmethyl-
TMP was veriﬁed (Scheme 1b). This TP is also a human metabolite
of TMP, along with 3-desmethyl-TMP and two N-oxides; in total,
around 2.2% of ingested TMP is excreted in the form of 4-
desmethyl-TMP (Sigel et al., 1973).
Table 1
Summary of kinetic results.
TMP spike concentration [mg/L] Sludge dilution Corresponding ﬁgure Estimate of kinetic order DT50 [d] kbiol L/(gSS$d) k'biol mg/(gSS$d)
5 1:1 with inﬂuent 2b Pseudo-ﬁrst-order 0.2 3.0 ± 0.1 5 ± 3
5 1:20 with efﬂuent 3b Zero-order 9.6 0.09 ± 0.01 0.23 ± 0.02
5 1:1 with efﬂuent 3c Pseudo-ﬁrst-order 1.2 0.63 ± 0.02 0.5 ± 0.3
500 1:1 with inﬂuent 2a Zero-order >14 0.03 ± 0.01 9 ± 4
500 1:20 with efﬂuent 3a No observed removal e e e
1a No dilution S16 Pseudo-ﬁrst Order 0.1 4.0 ± 0.5 e
Rate constants kbiol were determined by Equation (1) or (2) depending on the kinetic order: kbiol for pseudo-ﬁrst-order, k'biol for pseudo-zero-order. DT50 is time needed for
50% TMP removal, and ± indicate the uncertainty expressed as 95% conﬁdence intervals.
a Experiment conducted in the SBR running in batch mode (no cycling). The uncertainty was estimated by statistical analysis of the regression.
Fig. 3. Time courses of TMP and TPs in lab-scale reactor experiments with activated
sludge diluted with efﬂuent wastewater. TMP (C), TP306 (▫), TP324 (▵), 4-
desmethyl-TMP (-), TP292 (  ) and DAPC ( ). A: c0 ¼ 500 mg/L; efﬂuent:sludge
20:1 (n ¼ 2). B: c0 ¼ 5 mg/L; efﬂuent:sludge 20:1 (n ¼ 3). The dotted line represents a
zero-order kinetic model. C: c0 ¼ 5 mg/L; efﬂuent:sludge 1:1 (n ¼ 2).
Scheme 1. Observed TPs of TMP under aerobic conditions in activated sludge. A: Re-
actions dominating when 500 mg/L TMP were amended. TP306 and TP324 were pre-
viously reported by Eichhorn et al. (2005). B: Reactions found to dominate when 5 mg/L
TMP were amended to the reactor. The dashed arrow represents a minor pathway.
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293.12 and 291.11 (TMP has a m/z-ratio of 291.14, which can be
easily resolved). Both TPs showed a demethylation of one aromatic
methoxy group and the addition of oxygen and differed only by 2H
atoms indicating that a redox reaction took place. The position of
the oxygen on TP290 could be elucidated by the MS2 spectra,
showing that an additional oxygen atomwas inserted between the
phenolic and pyrimidine ring (see Supplementary data Fig. S6).
Since the formation of both TPs was closely related and as TP292
was formed before TP290, it can be concluded that TP290 was
formed by the oxidation of TP292 (see right graph in Fig. 2b). All
MS2 fragments of TP292 showed a loss of water which was not
observed in 4-desmethyl-TMP or TP290. This suggests that an
aliphatic hydroxyl group is located between the two aromatic rings,which was then oxidized to a ketone forming TP290.
The fourth TP of TMP had a smaller mass with only 155.06 and
was more stable in contrast to the other TPs formed. Hence, it
accumulated to higher concentration levels in the experiment.
Based on the molecular formula and the MS2 spectra it was
postulated that the pyrimidine ring of TMP was still unaltered,
while the di-methoxy-phenolic ring was cleaved and replaced by a
carboxylic moiety. Since a reference standard of this TP (2,4-
diaminopyrimidine-5-carboxylic acid, DAPC) was not commer-
cially available this TP was synthesized in our laboratory from the
ethyl ester derivative by ester hydrolysis (Eq. (3)).
K.S. Jewell et al. / Water Research 88 (2016) 550e557 555(3)
Details of this synthesis are given in the supplementary
information. The chemical structure of the synthesized DAPC,
veriﬁed by HRMS and MS2, was identical to DAPC formed in the
incubation experiments during TMP transformation. The quantiﬁ-
cation of DAPC showed that it accounted for 90% of the TMP portion
degraded in the incubation experiment (Fig. 2b). Hence, it can be
conﬁrmed that the proposed transformation pathway was domi-
nant in this experiment, leading to DAPC via 4-desmethyl-TMP,
TP292 and TP290 (Scheme 1b).
The sequence of the pathway was further veriﬁed by directly
spiking 4-desmethyl-TMP (500 mg/L) separately to a sludge-
inoculated reactor. In this experiment, 4-desmethyl-TMP was
immediately degraded and TP292, TP290 and DAPC were formed in
the same order as was observed when TMP was spiked (see
Supplementary data Fig. S8a). Although a slow removal of DAPC
could be observed (Fig. 2b), no further TPs could be identiﬁed. DAPC
was also previously found as a photodegradation product of TMP
(Michael et al., 2012).
TP306 was only observed in the experiments with high TMP
concentrations (500 mg/L), while TP324 was also detected in small
amounts when the reactor was amended with low concentrations
of 5 mg/L TMP at high dilution or when efﬂuent was used for dilu-
tion (Fig. 3b and c, respectively). It is therefore possible that under
these conditions, which are of intermediate TMP to biomass ratio,
pathway A (Scheme 1) plays a minor role. It cannot be totally ruled
out that TP306 can be demethylated intoTP292 and thus represents
a minor transformation pathway (dashed arrow in Scheme 1).
However, this demethylation was not seen in the experiments
spiked with 500 mg/L TMP, where TP306 formation was observed.
Obviously, the formation of TP306 and TP324 is favoured at higher
TMP to biomass ratios, and 4-desmethyl-TMP at lower TMP to
biomass ratios, but both reactions, demethylation and hydroxyl-
ation, can occur simultaneously as the initial TMP reaction.
3.3.3. Interpretation of the kinetic experiments and observed
transformation pathways
Based on the transformation pathways, the different kinetics
described in the previous section were caused by more than one
initial transformation reaction. At a high initial concentration of
TMP (500 mg/L), the previously reported hydroxylation reactions
(Eichhorn et al., 2005) were dominant (Scheme 1a), whereas at low
initial concentration (5 mg/L) a different pathway, beginning with
demethylation, was favoured (Scheme 1b). This example clearly
emphasises the importance of the concentration of antibiotics in
biodegradation experiments.
Several reasons can be postulated for this observation. One
possibility is a toxic/inhibition effect of the antibiotic TMP on bac-
teria/enzymes that are involved in TMP transformation. Although a
general toxic effect on sludge bacteria is rather unlikely, since for
sludge bacteria an EC50 of 16 mg/L TMP has been reported (Halling-
Sørensen et al., 2000), a toxic/inhibition effect on key species or
enzymes carrying out the demethylation of TMP cannot be ruled
out.
Another possibility is based on enzyme kinetics with different
enzyme saturations of two alternative transformation pathways
(Chen et al., 2010; Houston, 2006) or a similar effect caused by
differences in membrane transport kinetics. If the enzymes (or
transport proteins) of the demethylation pathway quickly reach
their saturation at higher TMP concentrations (i.e. the turnover
becomes limited by the amount of available free enzyme) thehydroxylation pathway would be favoured, if its enzyme saturation
is not reached so quickly. Thus, the hydroxylation rate would in-
crease proportional with the growing concentrations of TMP,
meaning these reactions become more dominant. On the other
hand at low TMP concentrations the pathway starting with
demethylation would be much faster than the hydroxylation
pathway and therefore dominates the TMP transformation.
A third possibility is a substrate induced adaption at higher TMP
concentrations promoting i) the growth of bacteria involved in the
TMP transformation by hydroxylation or ii) the expression of the
corresponding enzymes. An induced bacterial growth scenario is
considered unlikely, since a lag-phase in TMP removal would be
expected to occur in the high spike experiment (Fig. 2a), which was
not observed. However it cannot be excluded that an induced
enzyme expression of the existing community might be playing a
role. Further investigation could help to elucidate which scenarios
are more likely, for example toxicity studies, an examination of
enzyme kinetics or gene expression during the incubation experi-
ments. These were however not possible within the scope of this
study.
In the experiment where an elevated concentration of 500 mg/L
4-desmethyl-TMP was amended to the bioreactor containing a
highly diluted sludge (20:1), a fast removal was observed, compa-
rable to the less diluted sludge with a low TMP spike (compare
Fig. 2b and S8a in the Supplementary data). Thus, regardless of the
effect being kinetic or based on toxicity, obviously the O-deme-
thylation reaction is impacted themost by the higher concentration
of TMP.
3.4. Comparing kinetics and transformation pathways in the
laboratory and the SBR
3.4.1. Comparing the trimethoprim degradation kinetics between
laboratory- and pilot-scale
In the on-site SBR, where the TMP concentration is low and the
sludge concentration is high, it was expected that TMP trans-
formation would occur according to Fig. 2b (low spiking level,
5 mg/L, low dilution with inﬂuent wastewater) or the batch mode-
experiment at 1 mg/L (Supplementary data Fig. S16). To compare
this with the observed removal in the pilot reactor, a modelling
approach was used. Since studies of the anoxic removal of TMP
have found that it has rate constants comparable to, or lower than
those under aerobic conditions (Su et al., 2015; Burke et al., 2014),
two modelling scenarios were applied: one with similar removal
under aerobic and anoxic conditions and one with negligible
removal under anoxic conditions. Biological degradation in the
SBR was modelled at a ﬁxed inﬂuent concentration by iterating Eq.
(1) over 20 consecutive batches with a duration of 3 h, a sus-
pended solids concentration of 3.1 gSS/L as measured in the SBR,
and the kbiol value obtained from the batch-mode experiment (i.e.
4.0 L/(gSS∙d), Table 1). For the full equations, please refer to the
Supplementary Data. Based on the biological degradation model,
the predicted TMP removal in the SBR is 88% for the scenario with
no anoxic removal and 94% for the scenario with comparable
aerobic and anoxic removal rate constants. Both removal scenarios
are in good agreement with the average TMP removal of >83%
measured in the SBR during the operational period. Thus, the good
prediction of the model indicates that the laboratory experiment
with the low spiking level of 5 mg/L using only 1:1 diluted sludge
with inﬂuent wastewater (with an estimated kbiol of 3 L/(gSS∙d))
would provide the best comparability when modelling the SBR
with inﬂuent TMP concentrations in the range of 150 ng/L.
3.4.2. Occurrence of aerobic TPs in the on-site SBR
To compare the degradation pathway found in lab-scale
K.S. Jewell et al. / Water Research 88 (2016) 550e557556experiments with the SBR, the TPs present in the efﬂuent of the SBR
were measured. The aerobic/anoxic SBR was fed with municipal
wastewater containing 100e150 ng/L TMP (Fig. 1). Using sensitive
analytical methods based on detection via LCetandem MS, the SBR
efﬂuent was analysed for the presence of all TPs observed in the
lab-scale reactors reported in the previous section. The TP, 4-
desmethyl-TMP was detected only in a few 3-day composite sam-
ples of SBR efﬂuent with concentrations up to 14 ng/L. However, in
most cases this TP was not detected in the SBR efﬂuent above the
LOQ of 10 ng/L. The TP is an intermediate in the transformation
pathway (Scheme 1b) with a low steady-state concentration during
the laboratory experiments (Fig. 2b). This might explain its low
concentrations and sporadic detection in the SBR efﬂuent despite a
consistent removal of TMP during the same period. On the other
hand, 4-desmethyl-TMP is also a human metabolite of TMP (Sigel
et al., 1973). To conﬁrm that 4-desmethyl-TMP is indeed formed
from TMP in the SBR, the reactor was amended with 2.4 mg TMP/
reactor (200 ng/L) at the start of every cycle for a period of 12 h
(equivalent to the HRT). This led to an elevated concentration of
110 ng/L 4-desmethyl-TMP. This was clear evidence that the initial
demethylation of the transformation pathway observed in the lab-
scale experiments was also occurring in the on-site SBR.
However, under sterile and aerobic conditions 4-desmethyl-
TMPwas found to be unstable, since it was oxidized and hydrolysed
(for details please refer to the Supplementary data). These abiotic
reactions were found to involve oxidation and the subsequent
addition of nucleophiles. Since the wastewater matrix contains a
high number of nucleophiles, a large variety of addition products
could probably be formed after the oxidation of 4-desmethyl-TMP.
Similar additions of nucleophiles during wastewater treatment
were postulated for codeinone (a,b-unsaturated ketone) an un-
stable TP of the opiate analgesic codeine (Wick et al., 2011).
TP292 and 290 could not be detected in efﬂuent of the SBR, most
likely due to their low steady-state concentration, as already
observed in the lab-scale experiments. The quantitative analysis of
DAPC, the ﬁnal TP, was challenging due to its high polarity and low
molecular mass. Therefore, a pre-concentration step via SPE was
added prior to its detection in SBR inﬂuent and efﬂuent. DAPC could
be identiﬁed in the efﬂuent of the on-site SBR in a 3-day composite
sample by its MS2 fragmentation (please refer to Supplementary
data Fig. S18). For quantiﬁcation the standard addition method
was used. In a separate 3-day composite sample of the SBR efﬂuent,
taken several months later, 61 ng/L DAPC (TMP < 10 ng/L) was
detected (see Supplementary data Fig. S19), while it was not found
in the corresponding inﬂuent containing 221 ng/L of TMP. The
detected amount of DAPC accounts for 52% of the attenuated TMP.
Considering the results obtained so far, it is likely that the
remaining dissipation of TMP is caused by i) nucleophilic addition
of sludge constituents to 4-desmethyl-TMP leading to an array of
addition products, ii) a further transformation of DAPC to unknown
TPs.
The detection of 4-desmethyl-TMP and DAPC in the efﬂuent of
the SBR supports the hypothesis that the degradation pathway
(Scheme 1b) found in the lab-scale reactors is an important removal
pathway of TMP, occurring also in the SBR. Since neither TP306 nor
TP324 were detected in the SBR efﬂuent, the pathway (initiated by
hydroxylation) detected predominantly at higher spike concen-
trations, plays obviously no or only a very minor role for the SBR.
The variability of TMP removal in the SBR and in municipal WWTPs
(G€obel et al., 2005; Batt et al., 2006) is most likely caused by its
capability to enable the ﬁrst demethylation step forming 4-des-
methyl-TMP that is rapidly transformed to TP292, TP290 and DAPC.
Previous reports have found hydroxylation (Eichhorn et al.,
2005) or hydroxylation followed by catechol ring cleavage (Yi
et al., 2012), to be dominant removal processes of TMP. However,this is the ﬁrst study to our knowledge to show a different trans-
formation pathway of TMP occurring in a nitrifying/denitrifying
activated sludge reactor fed with municipal wastewater. Further
monitoring of TMP and the TPs found in this study, especially DAPC,
in full-scale WWTP efﬂuent will be part of follow-up studies. This
will help better judge the wider environmental occurrence of the
transformation pathway in different systems.
4. Conclusions
The analysis of transformation reactions in lab-scale bioreactors
is a useful tool to assess the transformation of micropollutants in
the environment. These ﬁndings show that the choice of the initial
analyte concentration may not only impact the kinetics of removal
but also the dominant reactions themselves can change. This might
lead to the transformation pathway stopping at an earlier stage or
different TPs becoming more dominant than what is more likely in
the natural environment. Although this is shown for one com-
pound, it could havewider implications for biodegradability testing
protocols, which often rely on elevated spike concentrations to aid
the analysis. This might be especially true for compounds with
antibacterial properties.
The alternative reactions at different TMP concentrations might
be linked to either limited turnover of speciﬁc enzymes or pro-
cesses or to toxic/inhibition or enzyme activation effects of TMP to
the sludge bacterial community at higher concentrations. In
particular, O-demethylation of TMP was no longer the dominant
reaction at high TMP concentrations. A biological analysis of the
sludge that is able to carry out O-demethylation or analysis of the
enzyme kinetics and how this is changed at higher concentrations
was beyond the scope of this investigation. However, this is an
important question for further study and may be helpful to un-
derstand the successful degradation of TMP and other micro-
pollutants found in wastewater.
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